The effect of lithium on thyroid function in patients with bipolar disorder;Wpływ stosowania litu na czynność gruczołu tarczowego u pacjentów z choroba̧ afektywna̧ dwubiegunowa̧

Psychiatria Polska

Volumn 48, Issue 3, 2014, Pages 417-428

  Kraszewska, Agnieszka ^a   Abramowicz, Maria ^a   Chłopocka Woźniak, Maria ^a   Sowiński, Jerzy ^b   Rybakowski, Janusz ^a  

^a Uniwersytetu Medycznego   (Poland)

^b Katedra i Klinika Endokrynologii   (Poland)

Author keywords

Bipolar disorder; Lithium; Thyroid

Indexed keywords

LITHIUM;

BIPOLAR DISORDER; HUMAN; LONG TERM CARE; PATIENT MONITORING; REVIEW; THYROID FUNCTION;

BIPOLAR DISORDER; GOITER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; LITHIUM COMPOUNDS; THYROID GLAND;

EID: 84904556840     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: 10.12740/pp/21684     Document Type: Review

References (59)

1. Hartigan G. The use of lithium salts in affective disorders. Br. J. Psychiatry 1963; 109: 810-814.
2. Rybakowski J. Leki normotymiczne. W: Wciórka J, Pużyński S, Rybakowski J. red. Psychiatria. Tom III. Wrocław: Elsevier Urban & Partner; 2012. s. 110-124.
3. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012; 379: 721-728.
4. Rybakowski J, Sowiński J. Free-thyroxine index and absolute free-thyroxine in affective disorders. Lancet 1973; 7808: 889.
5. Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso-Mateos JL. Evaluation of thyroid function in lithium-naive bipolar patients. Eur. Psychiatry 1999; 14: 341-345.
6. Ezzaher A, Haj Mouhamed D, Mechri A, Neffati F, Douki W, Gaha L. i wsp. Thyroid function and lipid profile in bipolar I patients. Asian J. Psychiatr. 2011; 4: 139-143.
7. Loosen PT. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocrinology 1985; 10: 237-260. (Pubitemid 16237734)
8. Linkowski P, Brauman H, Mendlewicz J. Thyrotrophin response to thyrotrophin-releasing hormone in unipolar and bipolar affective illness. J. Affect. Disord 1981; 3: 9-16. (Pubitemid 11147199)
9. Larsen JK, Faber J, Christensen EM, Bendsen BB, Solstad K, Gjerris A. i wsp. Relationship between mood and TSH response to TRH stimulation in bipolar affective disorder. Psychoneuroendocrinology 2004; 29: 917-924. (Pubitemid 38716117)
10. Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol. Psychiatry 2002; 51: 305-311. (Pubitemid 34214996)
11. Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? Biol. Psychiatry 2007; 62(2): 135-140. (Pubitemid 46963249)
12. Hillegers MH, Reichart CG, Wals M, Verhulst FC, Ormel J, Nolen WA. i wsp. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur. Neuropsychopharmacol. 2007; 17: 394-399. (Pubitemid 46497656)
13. Cowdry RW, Wehr TA, Zis AP, Goodwin FK. Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch. Gen. Psychiatry 1983; 40: 414-420. (Pubitemid 13118576)
14. Oomen HA, Schipperijn AJ, Drexhage HA. The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests. Clin. Endocrinol. (Oxf). 1996; 45: 215-223. (Pubitemid 26278316)
15. Cole DP, Thase ME, Mallinger AG, Soares JC, Luther JF, Kupfer DJ. i wsp. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am. J. Psychiatry 2002; 159: 116-121. (Pubitemid 41070736)
16. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch. Gen. Psychiatry 1996; 53: 842-848. (Pubitemid 26303624)
17. Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP. i wsp. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatry 2001; 158: 1617-1622. (Pubitemid 32923653)
18. Łojko D, Rybakowski JK. L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression. J. Affect. Disord. 2007; 103: 253-256. (Pubitemid 47445763)
19. Bauer M, Hellweg R, Gräf KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998; 18: 444-455. (Pubitemid 28202352)
20. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch. Gen. Psychiatry 1990; 47: 435-440. (Pubitemid 20161262)
21. Spaulding SW, Burrow GN, Bermudez F, Himmelhoch JM. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J. Clin. Endocrinol. Metab. 1972; 35: 905-911.
22. Berens SC, Wolff J, Murphy DL. Lithium concentration by the thyroid. Endocrinology 1970; 87: 1085-1087.
23. Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco NJ. Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity. J. Biol. Chem. 1997; 272: 27230-27238.
24. Lazarus JH, Kirov G, Harris B. Effect of lithium on thyroid and endocrine glands. W: Bauer M, Grof P, Müller-Oerlinghausen B. red. Lithium in neuropsychiatry. Oxfordshire: Informa Healthcare; 2006. s. 259-270.
25. Livingstone C, Rampes H. Lithium: a review of its metabolic adverse effects. J. Psychopharmacol. 2006; 20: 347-355.
26. Hahn CG, Pawlyk AC, Whybrow PC, Gyulai L, Tejani-Butt SM. Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sci. 1999; 64: 1793-1802. (Pubitemid 29215200)
27. Baumgartner A, von Stuckrad M, Müller-Oerlinghausen B, Gräf KJ, Kürten I. The hypothalamic-pituitary- thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy. J. Affect. Disord. 1995; 34: 211-218.
28. Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D. i wsp. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am. J. Psychiatry 1999; 156: 1909-1914.
29. Frye MA, Yatham L, Ketter TA, Goldberg J, Suppes T, Calabrese JR. i wsp. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar i maintenance studies. Acta Psychiatr. Scand. 2009; 120: 10-13.
30. Schou M, Amdisen A, Eskjaer Jensen S, Olsen T. Occurrence of goitre during lithium treatment. Br. Med. J. 1968; 3: 710-713.
31. Mannisto PT. Endocrine side-effects of lithium. W: Johnson FN. red. Handbook of lithium therapy. Lancaster: MTP Press; 1980. s. 310-322.
32. Perrild H, Hegedüs L, Baastrup PC, Kayser L, Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am. J. Psychiatry 1990; 147: 1518-1521. (Pubitemid 20365444)
33. Bocchetta A, Bernardi F, Pedditzi M, Loviselli A, Velluzzi F, Martino E. i wsp. Thyroid abnormalities during lithium treatment. Acta Psychiatr. Scand. 1991; 83:193-198.
34. Bocchetta A, Mossa P, Velluzzi F, Mariotti S, Del-Zompo M, Loviselli A. Ten year follow-up of thyroid function in lithium patients. J. Clin. Psychopharmacol. 2001; 21: 594-598. (Pubitemid 33116659)
35. Ozpoyraz N, Tamam L, Kulan E. Thyroid abnormalities in lithium treated patients. Adv. Ther 2002; 19: 176-184. (Pubitemid 35278524)
36. Caykoylu A, Capoglu I, Unuyvar N, Erdem F, Cetinkaya R. Thyroid abnormalities in lithium-treated patients with bipolar affective disorder. J. Int. Med. Res. 2002; 30: 80-84. (Pubitemid 34618726)
37. Schiemann U, Hengst K. Thyroid echogenicity in manic-depressive patients receiving lithium therapy. J. Affect. Disord. 2002; 70: 85-90. (Pubitemid 34756616)
38. Bauer M, Blumentritt H, Finke R, Schlattmann P, Adli M, Baethge C. i wsp. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders. J. Affect. Disord. 2007; 104: 45-51. (Pubitemid 350052301)
39. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 2003; 24: 102-132. (Pubitemid 36223282)
40. Martino E, Placidi GF, Sardano G, Mariotti S, Fornaro P, Pinchera A. i wsp. High incidence of goiter in patients treated with lithium carbonate. Ann. Endocrinol. 1982; 43: 269-276. (Pubitemid 13191769)
41. Ozsoy S, Mavili E, Aydin M, Turan T, Esel E. Ultrasonically determined thyroid volume and thyroid functions in lithium-naïve and lithium-treated patients with bipolar disorder: a cross-sectional and longitudinal study. Hum. Psychopharmacol. 2010; 25: 174-178.
42. Lazarus JH. Lithium and the thyroid gland. W: Lazarus JH. red. Endocrine and metabolic effects of lithium. New York, London: Plenum Medical Book Company; 1986. s. 99-124.
43. Bocchetta A, Cocco F, Velluzzi F, Del Zompo M, Mariotti S, Loviselli A. Fifteen-year follow-up of thyroid function in lithium patients. J. Endocrinol. Invest. 2007; 30: 363-366. (Pubitemid 47098230)
44. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br. J. Psychiatry 1999; 175: 336-339. (Pubitemid 29470863)
45. Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J. Affect. Disord. 2005; 87: 313-317. (Pubitemid 41039954)
46. Kleiner J, Altshuler L, Hendrick V, Hershman JM. Lithium-induced sublinical hypothyroidism: review of the literature and guidelines for treatment. J. Clin. Psychiatry 1999; 60: 249-255. (Pubitemid 29193924)
47. Franklin LM. Thyrotoxicosis developing during lithium treatment: case report. N. Z. Med. J. 1974; 79: 782.
48. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin. Endocrinol. 2001; 55: 501-508. (Pubitemid 32955488)
49. Kirov G. Thyroid disorders in lithium-treated patients. J. Affect. Disord. 1998; 50: 33-40. (Pubitemid 28338302)
50. Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin. Endocrinol. 1994; 40: 759-764. (Pubitemid 24216625)
51. Brownlie B, Turner J. Lithium associated thyrotoxicosis. Clin. Endocrinol. 2011; 75: 402-403.
52. Byrne AP, Delaney WJ. Regression of thyrotoxic ophthalmopathy following lithium withdrawal. Can. J. Psychiatry 1993; 38: 383-390.
53. Lazarus J, Richards A, Adison G, Owen G. Treatment of thyrotoxicosis with lithium carbonate. Lancet 1974, 2: 1160-168.
54. Wilson R, McKillop JH, Crocket GT, Pearson C, Jenkins C, Burns F. i wsp. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin. Endocrinol. 1991; 34: 357-361.
55. Baethge C, Blumentritt H, Berghöfer A, Bschor T, Glenn T, Adli M. i wsp. Long-term lithium treatment and thyroid antibodies: a controlled study. J. Psychiatry Neurosci. 2005; 30: 423-427. (Pubitemid 41812489)
56. Bocchetta A, Cherchi A, Loviselli A, Mossa P, Velluzzi F, Derai R. i wsp. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr. Scand. 1996; 94: 45-48. (Pubitemid 26238431)
57. Loviselli A, Bocchetta A, Mossa P, Velluzzi F, Bernardi F, del Zompo M. i wsp. Value of thyroid echography in the long-term follow-up of lithium-treated patients. Neuropsychobiology 1997; 36: 37-41. (Pubitemid 27243777)
58. Schiemann U, Hengst K. Thyroid echogenicity in manic-depressive patients receiving lithium therapy. J. Affect. Disord. 2002; 70: 85-90. (Pubitemid 34756616)
59. Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin. Pract. Epidemiol. Ment. Health 2006; 2: 23.